Longevity Medicine: Senolytics, NAD+ & mTOR

Quick answer: Biological aging can be measured and modified — rapamycin extends lifespan in mice by 25% even when started at age 20 months (Harrison 2009, Nature), senolytics dasatinib + quercetin reduced senescent cell burden by 35% in a clinical trial (Kirkland 2019, EBioMedicine), and exercise training reduces biological age by 4–8 years on epigenetic clocks. Functional longevity medicine addresses the nine hallmarks of aging — not just treating disease but reversing the underlying aging processes driving all chronic disease simultaneously.

The Nine Hallmarks of Aging: A Clinical Framework

López-Otín’s landmark 2013 Cell paper established the nine hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. The 2023 updated framework added three new hallmarks — disabled macroautophagy, chronic inflammation (inflammaging), and dysbiosis. Each hallmark is both a driver of aging and a therapeutic target.

Critically, the hallmarks are interconnected. Mitochondrial dysfunction generates ROS that cause genomic instability. Senescent cells secrete the senescence-associated secretory phenotype (SASP) — IL-6, IL-8, MMP-3, PAI-1 — which drives inflammaging and impairs stem cell niches. Epigenetic drift accelerates when NAD+ declines, as sirtuins (NAD+-dependent deacetylases) maintain epigenetic fidelity. This means longevity interventions that address one hallmark often benefit multiple simultaneously — rapamycin inhibits mTOR, which improves autophagy, reduces SASP, and restores proteostasis all at once.

Biological Age Measurement: Epigenetic Clocks and Functional Biomarkers

Chronological age is not biological age. Steve Horvath’s 2013 epigenetic clock (Genome Biology) predicts biological age from DNA methylation patterns at 353 CpG sites with R²=0.96 correlation with chronological age — but crucially, biological age can be 10–20 years younger or older than chronological age in the same cohort. The PhenoAge clock (Levine 2018, Aging) improved predictive validity for mortality using nine clinical biomarkers. GrimAge (Lu 2019) predicts time-to-death with hazard ratios of 1.51 per 5-year biological age acceleration.

Functional longevity biomarkers accessible in clinical practice include: grip strength (reduced by 30% predicts 60% higher all-cause mortality — Leong 2015, Lancet), VO2 max (each 3.5 mL/kg/min increase = 13% mortality reduction — Mandsager 2018, JAMA Network Open), resting heart rate variability (HRV decline precedes disease by years), fasting insulin (optimal <5 μIU/mL), hsCRP (optimal <0.5 mg/L), DHEA-S (declines 80% between age 25–80, tracks biological aging), and IGF-1 (anabolic/catabolic balance marker). The Levine PhenoAge calculator uses albumin, creatinine, glucose, CRP, lymphocyte %, MCV, RDW, alkaline phosphatase, and WBC — all from a standard CBC/CMP.

NAD+ Biology: The Master Longevity Molecule

NAD+ (nicotinamide adenine dinucleotide) is the central currency of aging biology. It serves as a substrate for sirtuins (SIRT1-7), which regulate epigenetics, mitochondrial biogenesis, DNA repair, and inflammation. It feeds PARP1, the primary DNA repair enzyme. It activates CD38 ecto-enzyme involved in immune function. NAD+ declines 50% between age 40 and 60 in human tissues, measured in plasma and muscle biopsies (Massudi 2012, PLoS One).

Precursor supplementation studies are now robust. Elhassan 2019 (Cell Reports) showed nicotinamide riboside (NR) 1,000 mg/day increased muscle NAD+ by 90% in older adults over 21 days. Martens 2018 (Nature Communications) showed NR 500 mg twice daily reduced aortic stiffness by 6% and systolic blood pressure by 8 mmHg in aged participants with elevated blood pressure. Yoshino 2021 (Science) found nicotinamide mononucleotide (NMN) 250 mg/day improved insulin sensitivity in postmenopausal women with prediabetes in a 10-week RCT. Dosing protocol: NMN 500–1000 mg/day or NR 500–1000 mg/day with resveratrol 250 mg (SIRT1 activator) for synergy.

mTOR and AMPK: The Longevity Signaling Switch

mTOR (mechanistic target of rapamycin) is the master anabolic sensor — it drives cell growth, protein synthesis, and proliferation when nutrients are abundant. But chronic mTOR overactivation accelerates aging: it suppresses autophagy (cellular garbage collection), drives senescence, and impairs stem cell quiescence. Rapamycin, the mTOR inhibitor originally discovered in Easter Island soil bacteria, extends median lifespan by 25% in mice starting at 20 months (equivalent to age 60 in humans) — Harrison 2009, Nature. In the ITP (Interventions Testing Program), rapamycin was the first intervention to extend lifespan when started in aged mice.

Dietary mTOR inhibitors include caloric restriction (reduces mTOR signaling 30–40%), time-restricted eating (16:8 fasting activates AMPK and suppresses mTOR), leucine-poor dietary periods, and berberine (AMPK activator). AMPK (AMP-activated protein kinase) is the opposing sensor — activated by low energy states, exercise, and metformin — it promotes autophagy, mitochondrial biogenesis, and fat oxidation while suppressing inflammatory NLRP3. The longevity goal is cycling between mTOR activation (anabolic periods — resistance training, adequate protein) and mTOR suppression (catabolic periods — fasting, zone 2 cardio) — the “metabolic flexibility” that prehistoric environments enforced naturally.

Senolytics and Senostatics: Clearing Zombie Cells

Senescent cells are cells that have permanently exited the cell cycle — triggered by DNA damage, telomere shortening, oncogene activation, or oxidative stress — and resist apoptosis. While normal senescence has roles in wound healing and embryonic development, accumulated senescent cells in aged tissues drive disease via the SASP. Baker 2011 (Nature) landmark study showed that clearing p16-positive senescent cells in progeroid mice prevented cataracts, muscle weakness, and fat loss — and extended healthspan by 25%. In naturally aged mice, senolytic clearance extended lifespan by 17–35% (Baker 2016, Nature).

The first human clinical trials of senolytics used dasatinib (tyrosine kinase inhibitor) + quercetin (flavonoid) in combination. Kirkland 2019 (EBioMedicine) showed D+Q administered intermittently (3 days on, 4 days off for 3 weeks) significantly reduced senescent cell burden in adipose tissue biopsy, reduced circulating SASP factors (PAI-1 by 25%, IL-6 by 18%), and improved physical function in patients with idiopathic pulmonary fibrosis. Quercetin alone at 500–1000 mg/day activates PI3K/Akt senolytic pathways. Fisetin, a flavonoid in strawberries, showed 30% senescent cell reduction in aged mice (Yousefzadeh 2018, EBioMedicine) at doses equivalent to ~20 mg/kg/day. Clinical protocol: dasatinib 100 mg + quercetin 1000 mg for 2–3 consecutive days, repeated quarterly.

Autophagy: Cellular Renewal and Proteostasis

Autophagy (“self-eating”) is the cellular recycling system that degrades damaged organelles, misfolded proteins, and intracellular pathogens via the lysosome. Autophagy declines with aging — driving the proteostasis collapse that underlies Alzheimer’s (amyloid accumulation), Parkinson’s (alpha-synuclein aggregates), and sarcopenia (damaged mitochondria). Yoshimori’s Nobel Prize 2016 recognized autophagy as fundamental to cellular health. Mitophagy (selective autophagy of damaged mitochondria) is particularly important for neurological and cardiovascular aging.

Autophagy activators with clinical evidence include: fasting/caloric restriction (24-hour fast increases autophagy markers 3-fold in liver — Alirezaei 2010, Autophagy); exercise (moderate-intensity exercise induces autophagy in muscle — He 2012, Nature); spermidine (polyamine found in wheat germ, aged cheese, mushrooms) — Eisenberg 2016 (Nature Medicine) showed spermidine supplementation extended lifespan in multiple organisms and reduced cardiovascular mortality in humans in a prospective study. Urolithin A (metabolite from pomegranate) — Ryu 2016 (Nature Medicine) showed it restored mitophagy and improved exercise tolerance in aged animals; Amazentis Phase 2 showed improved muscle strength in older adults. Rapamycin (1–6 mg/week intermittent dosing in clinical longevity practice) is the gold-standard autophagy inducer.

Telomere Biology: Length, Attrition, and Restoration

Telomeres are the protective caps on chromosomes that shorten with each cell division. When telomeres reach critical length, cells enter replicative senescence or apoptosis. Critically short telomeres predict mortality: Cawthon 2003 (Lancet) showed individuals in the shortest telomere quartile had 3-fold higher cardiovascular mortality and 8.5-fold higher infectious disease mortality. Average telomere attrition rate is ~50 bp/year in adulthood, but psychological stress, smoking, obesity, and sleep deprivation accelerate shortening by 2–3x.

Telomerase, the enzyme that lengthens telomeres, is normally silenced in somatic cells but active in stem cells and germ cells. TA-65 (cycloastragenol, extracted from Astragalus membranaceus) is the most studied telomerase activator — Harley 2011 (Rejuvenation Research) showed TA-65 supplementation shifted short telomere frequency and improved immune senescence markers. Lifestyle interventions demonstrably increase telomere length: Dean Ornish 2013 (Lancet Oncology) showed comprehensive lifestyle intervention (plant-based diet, meditation, exercise, social support) increased telomerase activity 29% and telomere length 10% over 5 years in prostate cancer patients. Omega-3 supplementation — Farzaneh-Far 2010 (JAMA) showed highest omega-3 quartile had 32% slower telomere attrition rate over 5 years.

Mitochondrial Longevity: PGC-1α, CoQ10, and Biogenesis

Mitochondrial dysfunction is both a hallmark of aging and a driver of all other hallmarks — mitochondria-derived ROS damage DNA, activate NLRP3 inflammasome, trigger cellular senescence, and impair stem cell function. PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is the master regulator of mitochondrial biogenesis — its expression declines 50% with aging in human skeletal muscle. Exercise is the most potent PGC-1α activator: zone 2 cardio (aerobic threshold) for 45 minutes 4x/week increases mitochondrial density 20–40% and improves VO2max 10–15% over 12 weeks in older adults.

CoQ10 (ubiquinol form) at 200–300 mg/day supports electron transport chain efficiency and reduces mitochondrial ROS. The Q-SYMBIO trial (Mortensen 2014, JACC Heart Failure) showed CoQ10 200 mg 3x/day reduced cardiovascular mortality 43% in heart failure patients. Alpha-lipoic acid (ALA) recycled both glutathione and CoQ10 while chelating heavy metals. R-ALA (reduced isomer) at 300–600 mg/day is the bioactive form. Pyrroloquinoline quinone (PQQ) at 20 mg/day upregulates PGC-1α and stimulates mitochondrial biogenesis independently of exercise — Harris 2013 (Journal of Nutritional Biochemistry).

Inflammaging: Chronic Low-Grade Inflammation and Longevity

Inflammaging — the chronic low-grade sterile inflammation that increases with aging — drives atherosclerosis, neurodegeneration, sarcopenia, and cancer simultaneously. IL-6, TNF-α, IL-1β, and hsCRP are elevated in centenarians’ children (familial longevity) at 30–40% lower levels vs age-matched controls (Atzmon 2006, JAGS). NLRP3 inflammasome, activated by damaged mitochondria, crystals (urate, cholesterol), and gut-derived LPS, is a central driver. Colchicine 0.5 mg/day — the LODOCO2 trial (2019, NEJM) showed a 23% reduction in cardiovascular events in stable CAD patients by inhibiting NLRP3-mediated inflammation.

Anti-inflammaging dietary strategies: Mediterranean diet (PREDIMED 2013, NEJM — 30% CVD event reduction), omega-3 EPA+DHA 3–4 g/day (reduces IL-6 by 20–30%), polyphenol-rich berries (pterostilbene, fisetin, quercetin activate SIRT1 and suppress NF-κB), sulforaphane from broccoli sprouts (activates NRF2, suppresses NLRP3 — Kim 2017, Journal of Neuroinflammation), and elimination of ultra-processed foods (Fung 2019, Cell). The resolution of inflammation is equally important — omega-3 derived resolvins and protectins are specialized pro-resolving mediators (SPMs) that actively terminate inflammation rather than merely suppressing it (Serhan 2014, Nature).

Exercise as the Most Potent Longevity Intervention

Exercise simultaneously addresses more hallmarks of aging than any drug: it activates AMPK, induces autophagy and mitophagy, increases mitochondrial density via PGC-1α, stimulates BDNF for neurogenesis, improves insulin sensitivity, reduces inflammaging via IL-6 myokine signaling, extends telomere length, and directly increases healthspan and lifespan. Mandsager 2018 (JAMA Network Open) analyzed 122,007 patients and found that elite cardiorespiratory fitness (CRF ≥ 97th percentile) conferred a hazard ratio of 0.23 for mortality vs. the least-fit group — a 77% mortality reduction, exceeding the effect of statin therapy, antihypertensives, or most medical interventions combined.

The optimal longevity exercise prescription combines zone 2 training (aerobic base — 45–60 min, 4x/week, lactate threshold 2 mmol/L) with resistance training (2–3x/week, progressive overload for sarcopenia prevention) and zone 5 intervals (VO2max stimulation — 4×4 HIIT weekly). Zone 2 cardio maximizes mitochondrial biogenesis and metabolic flexibility. Resistance training prevents the 3–8% per decade muscle mass decline of sarcopenia that begins at age 30, which predicts falls, fractures, and disability. The combination produces synergistic effects not achieved by either modality alone (Hawley 2009, Cell Metabolism).

Longevity Nutrition: Protein, Fasting, and Caloric Restriction

Protein intake is paradoxically complex in longevity nutrition. Levine 2014 (Cell Metabolism) found high animal protein intake (>20% of calories) was associated with 4-fold increased cancer mortality and 74% increased all-cause mortality in adults aged 50–65 — but this association reversed in adults over 65, where low protein increased mortality (sarcopenia risk). The reconciliation: adequate leucine-containing quality protein (1.2–1.6 g/kg/day) for muscle protein synthesis in older adults, with protein timing (0.4 g/kg post-exercise), while maintaining mTOR cycling through intermittent fasting periods.

Caloric restriction (CR) at 20–30% below ad libitum extends lifespan in every organism studied from yeast to primates — the CALERIE trial (Ravussin 2015, Cell Metabolism) showed 25% CR for 2 years reduced biological aging markers, cardiovascular risk factors, and systemic inflammation in healthy adults. Fasting-mimicking diets (FMD — Valter Longo’s ProLon protocol: 5 days/month at 40–50% caloric restriction with plant-based macronutrients) reduced IGF-1 by 15%, fasting glucose by 8 mg/dL, and biological age by 2.5 years vs. control in a 3-month RCT (Brandhorst 2015, Cell Metabolism). Intermittent fasting (16:8 or 5:2) activates many CR pathways including AMPK, autophagy, and sirtuins without requiring chronic caloric restriction.

The Longevity Supplement Stack: Evidence-Based Protocols

Interventions Testing Program (ITP) — a rigorous multi-institution mouse lifespan testing program — has validated: rapamycin (25% lifespan extension, started late), acarbose (22% extension in males), 17-α-estradiol (19% in males), and a combination of rapamycin + metformin. Human longevity supplement protocols based on the strongest evidence include: NAD+ precursors (NMN 500 mg or NR 500 mg/day), spermidine 1.2–3 mg/day, urolithin A 500–1000 mg/day, quercetin 500–1000 mg (senolytic cycling), fisetin 100–200 mg/day, resveratrol 250–500 mg/day (SIRT1 activator, pairs with NAD+ precursors), CoQ10 ubiquinol 200–300 mg/day, omega-3 EPA+DHA 3–4 g/day, vitamin D3 to 60–80 ng/mL, magnesium glycinate 400 mg/day, and PQQ 20 mg/day.

Metformin, the most prescribed diabetes drug, reduces all-cause mortality and cancer risk beyond its glucose effects. TAME trial (Targeting Aging with Metformin) is an ongoing $75M NIH-funded RCT testing 1500 mg/day in non-diabetic older adults specifically to slow biological aging. Observational data: Bannister 2014 (Diabetes, Obesity and Metabolism) found metformin users had lower all-cause mortality than matched diabetic non-users AND non-diabetic controls — the only drug ever to show benefit vs. healthy individuals in epidemiology. Appropriate candidates: patients with metabolic syndrome, insulin resistance, APOE4 carriers, or those with strong family history of age-related diseases.

Hormonal Optimization and Longevity

Hormone decline is both a consequence and accelerant of aging. DHEA declines 80% by age 80 from its peak at age 25 — it converts to testosterone and estrogen in peripheral tissues, supports immune function, and reduces inflammaging. Low DHEA-S predicts cardiovascular mortality (Trivedi 2011, European Heart Journal). Supplementation with DHEA 25–50 mg/day in those with DHEA-S below 100 μg/dL restores physiological levels and improves immune senescence markers. Testosterone in men (optimal 600–900 ng/dL free testosterone in proportion) declines 1–2% per year after 30 — the TRAVERSE trial (2023, NEJM) definitively showed TRT did not increase cardiovascular events while reducing fracture risk and improving sexual function.

Growth hormone (GH) and IGF-1 have a complex longevity relationship. While GH decline (somatopause) causes sarcopenia and visceral fat accumulation, high IGF-1 increases cancer risk — Laron dwarfism (complete GH resistance) confers protection against cancer and diabetes (Guevara-Aguirre 2011, Science Translational Medicine). The functional approach uses peptide therapy to restore GH pulse amplitude without continuous IGF-1 elevation: CJC-1295/Ipamorelin combination at physiological doses restores GH pulses without suppressing the GH-IGF-1 feedback axis. Growth hormone secretagogues that mimic the pulsatile GH pattern of youth (not continuous infusion) represent a safer approach than exogenous GH.

Sleep, Circadian Rhythm, and Longevity

Sleep is the most undervalued longevity intervention. The glymphatic system, discovered by Maiken Nedergaard 2013 (Science), flushes amyloid-beta, tau, and metabolic waste from the brain during slow-wave sleep — with 10–20x more clearance than during waking. Chronic short sleep (<6 hours) increases Alzheimer's risk 30%, cardiovascular mortality 48%, immune dysregulation, and accelerates epigenetic aging by 1–2 years. Walker 2019 showed 1-hour less sleep per night for 1 week reduced natural killer cell activity 70% — the equivalent of the immune suppression of a single night of alcohol consumption.

Circadian biology optimization is as important as sleep duration. Zeitgebers (time-givers) that anchor the circadian clock include: morning bright light (10,000 lux for 10–20 min upon waking), time-restricted eating aligned with daylight (first meal within 1–2 hours of sunrise, last meal 3+ hours before sunset), evening blue light elimination after 9pm, and consistent sleep-wake times (±30 minutes). Shift workers have 23% higher all-cause mortality — circadian disruption per se, independent of sleep quantity, accelerates aging (Scheer 2009, PNAS). Functional assessment: dim-light melatonin onset (DLMO) salivary testing reveals true circadian phase vs. reported sleep timing.

Psychological Resilience, Social Connection, and Longevity

Holt-Lunstad’s 2015 meta-analysis (Perspectives on Psychological Science, 148 studies, 308,849 participants) found social isolation increased mortality risk by 29% — equivalent to smoking 15 cigarettes/day and exceeding the effects of obesity. Loneliness accelerates epigenetic aging, increases inflammatory cytokines, and shortens telomeres. The Harvard Study of Adult Development — the world’s longest study of adult life (80+ years, tracking 724 men from 1938) — found relationship quality at age 50 was the single best predictor of health at age 80, superior to cholesterol, blood pressure, or any biomarker.

Psychological aging interventions with biological evidence: mindfulness meditation reduces cortisol 14% and increases telomerase activity 30% after 3-month intensive practice (Jacobs 2011, Psychoneuroendocrinology); purpose/meaning (higher eudaimonic wellbeing) reduced all-cause mortality 30% over 8 years (Hill 2014, Psychological Science); and voluntary helping behaviors were associated with lower cortisol reactivity and attenuated inflammatory responses. The Blue Zone populations (Okinawa, Sardinia, Loma Linda, Nicoya, Ikaria) share: plant-forward whole food diets, daily movement as lifestyle, strong social networks, sense of purpose (ikigai/plan de vida), and stress-reduction practices — no single intervention explains their exceptional longevity.

Functional Longevity Assessment Protocol

A comprehensive longevity evaluation includes: biological age assessment (PhenoAge from CBC/CMP, optional TruDiagnostic epigenetic clock), metabolic panel (fasting insulin, HbA1c, HOMA-IR, lipid particle size, APOB, LP(a)), inflammatory panel (hsCRP, IL-6, TNF-α, fibrinogen), hormonal panel (testosterone total/free/SHBG, DHEA-S, IGF-1, fasting leptin, thyroid panel), nutritional markers (25-OH vitamin D, omega-3 index, magnesium RBC, CoQ10, homocysteine, methylmalonic acid), genetic variants (APOE, MTHFR, COMT for targeted supplementation), and functional testing (grip strength, 6-minute walk test or VO2max estimation, cognitive function assessment).

Annual re-measurement tracks biological age trajectory — the goal being biological age deceleration or reversal. Horvath’s 2013 study showed that behavioral interventions can produce epigenetic age changes of 1–3 years within 6–12 months. The Ornish 2013 Lancet Oncology study showed 10% increase in telomere length and 29% increase in telomerase activity in 5 years with comprehensive lifestyle change. This means measurable reversal of biological aging is achievable in clinical practice — not merely theoretical. Our practice at (810) 206-1402 offers comprehensive longevity panels and personalized healthspan optimization protocols integrating all evidence-based interventions discussed here.

Longevity Medicine: Senolytics, NAD+, mTOR, Autophagy, and the Hallmarks of Aging